TP53 and prostate neoplasm: For example, ERG rearrangements (11, 22–24), PTEN deletions (7, 11, 23, 24), and TP53 alterations (14–16, 25) have been identified by our group and others as reproducibly less common among prostate tumors from BL compared with WH men.